Market LIVE
Published markets; coverage varies by country
Product profile · United States

DOCETAXEL

 ·  Patent Litigation & Settlement History ↓

IngredientDOCETAXEL
Application typeNDA
Application202356
Product003
Dosage formINJECTABLE
RouteINJECTION
Strength130MG/13ML (10MG/ML)
Approval date2014-03-13
Marketing statusDiscontinued
Status event2019-05-01
ApplicantPFIZER LABS
Product source

Current GenericRadar decision

Year2019
SelectionWITHDRAWN
ReviewFINAL
Anchor typeFDA_APPROVAL_WITHDRAWAL_EFFECTIVE_DATE
Anchor date2019-05-01
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event2019-05-01

FDA_LEGAL_APPROVAL_WITHDRAWAL; canonical 2014 DEEP_REVIEW; APPROVAL_YEAR_FALLBACK. FDA legal approval withdrawal effective date, not notice publication.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-12 · NO_REGULATORY_EXCLUSIVITY_IDENTIFIED · Historical coverage: ANNUALS_2011_2026_REVIEWED

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (1)
TypeDateRoleBasisSource
REGULATORY_STATUS2019-05-01TERMINAL_STATUSFDA_LEGAL_APPROVAL_WITHDRAWAL; canonical 2014 DEEP_REVIEW; APPROVAL_YEAR_FALLBACK. FDA legal approval withdrawal effective date, not notice publication.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.